| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9978987 | The Journal of Thoracic and Cardiovascular Surgery | 2005 | 7 Pages |
Abstract
Despite more demanding surgical technique than with conventional bioprostheses, the CryoLife-O'Brien bioprosthesis can be implanted safely in a population predominantly older than 70 years at the time of the operation, with excellent measures of hemodynamics, clinical outcomes, prosthesis durability, and survival through 8 years.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Ivo MD, Ibrahim MD, Manfred MD, Stephan MD, Igor MD, Thomas MD, Hans MD, PhD, Paul MD, PhD,